Evusheld Archives - Express Pharma

EU recommends marketing approval for Evusheld to treat COVID-19

US plans to move COVID vaccines and treatments to private markets in 2023

AstraZeneca boosts COVID portfolio with RQ Bio deal

EU approves Evusheld for preventing COVID-19

Evusheld recommended for approval in EU for prevention of COVID-19

We remain optimistic that Evusheld will retain its efficacy against Omicron variant

Israel to offer AstraZeneca’s Evusheld to immunocompromised people

AstraZeneca welcomes US government’s announcement to purchase additional 500,000 doses of Evusheld

Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in independent FDA study

US FDA grants EUA to AstraZeneca’s Evusheld in US for pre-exposure prophylaxis of COVID-19